Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch
ConditionPruritus
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
The purpose of this study is to determine if cervical traction is an effective treatment to reduce GABAergic medication use for scalp, arm, and upper back neuropathic itch.
Eligibility criteria
Qualifiers
Persons with scalp, arm, and upper back pruritus without primary skin lesions.
Persons 18 or older.
Person on a stable dosage of gabapentin or pregabalin over the preceding 4 week period.
Persons willing and able to comply with clinic visits and study-related procedures.
Disqualifiers
Primary skin lesions driving scalp, arm, or upper back pruritus.
A history of spinal surgery or other conditions (acute or traumatic spinal injury, spinal instability, spinal fracture, rheumatoid arthritis, metastatic disease to the spine, spinal cord compression, active infections of the head and neck) that would make neck traction contraindicated.
Unable to comfortably lay down on the floor and get back up without assistance.
Medical conditions in which gabapentin and/or pregabalin is contraindicated.
Trial design
Treatments tested in this trial
- Cervical Traction Device
Treatment groups
12 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov